The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, G.-X.
Right arrow Articles by Rostami, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, G.-X.
Right arrow Articles by Rostami, A.
The Journal of Immunology, 2003, 170: 2153-2160.
Copyright © 2003 by The American Association of Immunologists

Induction of Experimental Autoimmune Encephalomyelitis in IL-12 Receptor-{beta}2-Deficient Mice: IL-12 Responsiveness Is Not Required in the Pathogenesis of Inflammatory Demyelination in the Central Nervous System1

Guang-Xian Zhang*, Bruno Gran*, Shuo Yu*, Jifen Li{ddagger}, Ines Siglienti*, Xiaohan Chen{dagger}, Malek Kamoun{ddagger} and Abdolmohamad Rostami2,*

Departments of * Neurology, {dagger} Neurosurgery, and {ddagger} Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104

IL-12 is thought to be involved in the susceptibility to experimental autoimmune encephalomyelitis (EAE), a Th1 cell-mediated autoimmune disorder of the CNS. IL-12 signals through a heterodimeric receptor (IL-12R{beta}1/IL-12R{beta}2), whose {beta}2-chain is up-regulated on activated, autoreactive Th1 cells. Contrary to the expectation that the absence of IL-12R{beta}2 would protect from EAE, we found that IL-12R{beta}2-deficient mice developed earlier and more severe disease, with extensive demyelination and CNS inflammation. The inflammatory cells were mainly comprised of CD4+ T cells, monocyte/macrophages, and dendritic cells. Compared to wild-type mice, IL-12R{beta}2-deficient mice exhibited significantly increased autoantigen-induced proliferative response and increased production of TNF-{alpha}, GM-CSF, IL-17, IL-18/IL-18R{alpha}, and NO. In addition, we found significantly increased levels of IL-23p19 mRNA expression in spleen cells from immunized IL-12R{beta}2-/- mice compared with wild-type mice. These findings indicate that IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the CNS, and that, in the absence of IL-12R{beta}2, increased IL-23 and other inflammatory molecules may be responsible for increased severity of EAE.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Li, G.-X. Zhang, Y. Chen, H. Xu, D. C. Fitzgerald, Z. Zhao, and A. Rostami
CD11c+CD11b+ Dendritic Cells Play an Important Role in Intravenous Tolerance and the Suppression of Experimental Autoimmune Encephalomyelitis
J. Immunol., August 15, 2008; 181(4): 2483 - 2493.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Doi, S. Oki, T. Ozawa, H. Hohjoh, S. Miyake, and T. Yamamura
Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines
PNAS, June 17, 2008; 105(24): 8381 - 8386.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Reinwald, C. Wiethe, A. M. Westendorf, M. Breloer, M. Probst-Kepper, B. Fleischer, A. Steinkasserer, J. Buer, and W. Hansen
CD83 Expression in CD4+ T Cells Modulates Inflammation and Autoimmunity
J. Immunol., May 1, 2008; 180(9): 5890 - 5897.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
D. Luger, P. B. Silver, J. Tang, D. Cua, Z. Chen, Y. Iwakura, E. P. Bowman, N. M. Sgambellone, C.-C. Chan, and R. R. Caspi
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category
J. Exp. Med., April 14, 2008; 205(4): 799 - 810.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M. Oukka
Interplay between pathogenic Th17 and regulatory T cells
Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii87 - iii90.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. M. Hildner, P. Schirmacher, I. Atreya, M. Dittmayer, B. Bartsch, P. R. Galle, S. Wirtz, and M. F. Neurath
Targeting of the Transcription Factor STAT4 by Antisense Phosphorothioate Oligonucleotides Suppresses Collagen-Induced Arthritis
J. Immunol., March 15, 2007; 178(6): 3427 - 3436.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Thakker, M. W. Leach, W. Kuang, S. E. Benoit, J. P. Leonard, and S. Marusic
IL-23 Is Critical in the Induction but Not in the Effector Phase of Experimental Autoimmune Encephalomyelitis
J. Immunol., February 15, 2007; 178(4): 2589 - 2598.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. H. Hofstetter, K. V. Toyka, M. Tary-Lehmann, and P. V. Lehmann
Kinetics and Organ Distribution of IL-17-Producing CD4 Cells in Proteolipid Protein 139-151 Peptide-Induced Experimental Autoimmune Encephalomyelitis of SJL Mice
J. Immunol., February 1, 2007; 178(3): 1372 - 1378.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. M. Wozniak, A. A. Ryan, and W. J. Britton
Interleukin-23 Restores Immunity to Mycobacterium tuberculosis Infection in IL-12p40-Deficient Mice and Is Not Required for the Development of IL-17-Secreting T Cell Responses
J. Immunol., December 15, 2006; 177(12): 8684 - 8692.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S. Schnyder-Candrian, D. Togbe, I. Couillin, I. Mercier, F. Brombacher, V. Quesniaux, F. Fossiez, B. Ryffel, and B. Schnyder
Interleukin-17 is a negative regulator of established allergic asthma
J. Exp. Med., November 27, 2006; 203(12): 2715 - 2725.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Komiyama, S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura
IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis
J. Immunol., July 1, 2006; 177(1): 566 - 573.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-L. Cho, J.-W. Kang, Y.-M. Moon, H.-J. Nam, J.-Y. Jhun, S.-B. Heo, H.-T. Jin, S.-Y. Min, J.-H. Ju, K.-S. Park, et al.
STAT3 and NF-{kappa}B Signal Pathway Is Required for IL-23-Mediated IL-17 Production in Spontaneous Arthritis Animal Model IL-1 Receptor Antagonist-Deficient Mice
J. Immunol., May 1, 2006; 176(9): 5652 - 5661.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. M. Tato, A. Laurence, and J. J. O'Shea
Helper T cell differentiation enters a new era: Le Roi est mort; vive le Roi!
J. Exp. Med., April 17, 2006; 203(4): 809 - 812.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. M. Frohman, M. K. Racke, and C. S. Raine
Multiple sclerosis--the plaque and its pathogenesis.
N. Engl. J. Med., March 2, 2006; 354(9): 942 - 955.
[Full Text] [PDF]


Home page
J. Nutr.Home page
M. K. Racke, A. R. Gocke, M. Muir, A. Diab, P. D. Drew, and A. E. Lovett-Racke
Nuclear Receptors and Autoimmune Disease: The Potential of PPAR Agonists to Treat Multiple Sclerosis
J. Nutr., March 1, 2006; 136(3): 700 - 703.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Matsuki, S. Nakae, K. Sudo, R. Horai, and Y. Iwakura
Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis
Int. Immunol., February 1, 2006; 18(2): 399 - 407.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G.-X. Zhang, S. Yu, B. Gran, and A. Rostami
Glucosamine Abrogates the Acute Phase of Experimental Autoimmune Encephalomyelitis by Induction of Th2 Response
J. Immunol., December 1, 2005; 175(11): 7202 - 7208.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. P. Lewkowich, J. D. Rempel, and K. T. HayGlass
Prevention of Allergen-Specific, Th2-Biased Immune Responses In Vivo: Role of Increased IL-12 and IL-18 Responsiveness
J. Immunol., October 15, 2005; 175(8): 4956 - 4962.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
Y. Kihara, S. Ishii, Y. Kita, A. Toda, A. Shimada, and T. Shimizu
Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor
J. Exp. Med., September 19, 2005; 202(6): 853 - 863.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. A. Khader, J. E. Pearl, K. Sakamoto, L. Gilmartin, G. K. Bell, D. M. Jelley-Gibbs, N. Ghilardi, F. deSauvage, and A. M. Cooper
IL-23 Compensates for the Absence of IL-12p70 and Is Essential for the IL-17 Response during Tuberculosis but Is Dispensable for Protection and Antigen-Specific IFN-{gamma} Responses if IL-12p70 Is Available
J. Immunol., July 15, 2005; 175(2): 788 - 795.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. L. Langrish, Y. Chen, W. M. Blumenschein, J. Mattson, B. Basham, J. D. Sedgwick, T. McClanahan, R. A. Kastelein, and D. J. Cua
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
J. Exp. Med., January 18, 2005; 201(2): 233 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Fairweather, S. Frisancho-Kiss, S. A. Yusung, M. A. Barrett, S. E. Davis, R. A. Steele, S. J. L. Gatewood, and N. R. Rose
IL-12 Protects against Coxsackievirus B3-Induced Myocarditis by Increasing IFN-{gamma} and Macrophage and Neutrophil Populations in the Heart
J. Immunol., January 1, 2005; 174(1): 261 - 269.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. Fairweather, S. Frisancho-Kiss, S. A. Yusung, M. A. Barrett, S. E. Davis, S. J.L. Gatewood, D. B. Njoku, and N. R. Rose
Interferon-{gamma} Protects against Chronic Viral Myocarditis by Reducing Mast Cell Degranulation, Fibrosis, and the Profibrotic Cytokines Transforming Growth Factor-{beta}1, Interleukin-1{beta}, and Interleukin-4 in the Heart
Am. J. Pathol., December 1, 2004; 165(6): 1883 - 1894.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. R. Kanwar, R. K. Kanwar, and G. W. Krissansen
Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis
Brain, June 1, 2004; 127(6): 1313 - 1331.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. A. W. Verreck, T. de Boer, D. M. L. Langenberg, M. A. Hoeve, M. Kramer, E. Vaisberg, R. Kastelein, A. Kolk, R. de Waal-Malefyt, and T. H. M. Ottenhoff
Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria
PNAS, March 30, 2004; 101(13): 4560 - 4565.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Ghilardi, N. Kljavin, Q. Chen, S. Lucas, A. L. Gurney, and F. J. de Sauvage
Compromised Humoral and Delayed-Type Hypersensitivity Responses in IL-23-Deficient Mice
J. Immunol., March 1, 2004; 172(5): 2827 - 2833.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. A. Murphy, C. L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
J. Exp. Med., December 15, 2003; 198(12): 1951 - 1957.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
A. Suzumura, A. Ito, and T. Mizuno
Phosphodiesterase inhibitors suppress IL-12 production with microglia and T helper 1 development
Multiple Sclerosis, December 1, 2003; 9(6): 574 - 578.
[Abstract] [PDF]


Home page
J. Immunol.Home page
G.-X. Zhang, S. Yu, B. Gran, J. Li, I. Siglienti, X. Chen, D. Calida, E. Ventura, M. Kamoun, and A. Rostami
Role of IL-12 Receptor {beta}1 in Regulation of T Cell Response by APC in Experimental Autoimmune Encephalomyelitis
J. Immunol., November 1, 2003; 171(9): 4485 - 4492.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.